Charter Medical (LDL) Receives CE Mark Clearance for Next Generation Cell Freeze Cryogenic Stem Cell Storage
Go back to Charter Medical (LDL) Receives CE Mark Clearance for Next Generation Cell Freeze Cryogenic Stem Cell Storage| LYDALL, Inc. (NYSE: LDL) | Delayed: 62.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.09 | 52 Week High | $56.75 | |||
| Open | $8.03 | 52 Week Low | $25.41 | |||
| Day High | $62.09 | P/E | 60.28 | |||
| Day Low | $62.09 | EPS | $1.03 | |||
| Volume | 14,293 | |||||
